Drug intelligence / Profile preview

porcine reproductive and respiratory syndrome virus vaccine

Development stage
Preclinical
Lead developer
ECO Animal Health Group
Modality
Vaccines & Immunotherapeutics
Administration
Intramuscular, Intranasal
01

Overview

The Porcine Reproductive and Respiratory Syndrome Virus (PRRSV) vaccine is a preclinical-stage veterinary vaccine being developed by The Vaccine Group (TVG). It utilizes TVG's proprietary recombinant herpesvirus viral vector platform to deliver PRRSV antigens. The vaccine is designed to protect pigs against PRRSV infection, which causes reproductive failure in sows and respiratory disease in piglets. Preclinical studies have demonstrated the induction of T-cell immunogenicity and prevention of lung disease in pigs.

Other names
PRRSV vaccinePorcine Reproductive and Respiratory Syndrome vaccine
02

Targets

Porcine reproductive and respiratory syndrome virus envelope glycoprotein complex (Glycoprotein 2, Glycoprotein 3, Glycoprotein 4, Glycoprotein 5, and Matrix protein)Porcine reproductive and respiratory syndrome virus envelope glycoprotein GP5Porcine reproductive and respiratory syndrome virus envelope glycoprotein GP5 (PRRSV GP5)

Beyond the preview

Go deeper on porcine reproductive and respiratory syndrome virus vaccine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on porcine reproductive and respiratory syndrome virus vaccine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call